242 related articles for article (PubMed ID: 33855695)
1. Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
Scheinberg P
Br J Haematol; 2021 Sep; 194(6):954-969. PubMed ID: 33855695
[TBL] [Abstract][Full Text] [Related]
2. Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.
Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
BMC Immunol; 2020 Mar; 21(1):10. PubMed ID: 32138642
[TBL] [Abstract][Full Text] [Related]
3. [Acquired aplastic anemia: recent advances in pathophysiology and treatment].
Yamazaki H
Rinsho Ketsueki; 2018; 59(6):711-715. PubMed ID: 29973449
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.
Hwang YY; Gill H; Chan TSY; Leung GMK; Cheung CYM; Kwong YL
Hematology; 2018 Aug; 23(7):399-404. PubMed ID: 29303047
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the diagnosis and management of adult aplastic anaemia.
Killick SB; Bown N; Cavenagh J; Dokal I; Foukaneli T; Hill A; Hillmen P; Ireland R; Kulasekararaj A; Mufti G; Snowden JA; Samarasinghe S; Wood A; Marsh JC;
Br J Haematol; 2016 Jan; 172(2):187-207. PubMed ID: 26568159
[No Abstract] [Full Text] [Related]
6. Management of the refractory aplastic anemia patient: what are the options?
Marsh JC; Kulasekararaj AG
Hematology Am Soc Hematol Educ Program; 2013; 2013():87-94. PubMed ID: 24319168
[TBL] [Abstract][Full Text] [Related]
7. Eltrombopag in aplastic anemia.
Desmond R; Townsley DM; Dunbar C; Young NS
Semin Hematol; 2015 Jan; 52(1):31-7. PubMed ID: 25578417
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
Groarke EM; Patel BA; Gutierrez-Rodrigues F; Rios O; Lotter J; Baldoni D; St Pierre A; Shalhoub R; Wu CO; Townsley DM; Young NS
Br J Haematol; 2021 Feb; 192(3):605-614. PubMed ID: 33410523
[TBL] [Abstract][Full Text] [Related]
9. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia.
Geng W; Kearney S; Nelson S
Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
Scheinberg P
Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
[TBL] [Abstract][Full Text] [Related]
11. Eltrombopag for the treatment of aplastic anemia: current perspectives.
Lum SH; Grainger JD
Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
[TBL] [Abstract][Full Text] [Related]
12. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic choices in immune aplastic anemia.
Scheinberg P
F1000Res; 2020; 9():. PubMed ID: 32953089
[TBL] [Abstract][Full Text] [Related]
14. Supportive Care and Newer Therapies in Aplastic Anaemia.
Malhotra P; John JM
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):26-9. PubMed ID: 26529864
[No Abstract] [Full Text] [Related]
15. The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
Ames NJ; Barb JJ; Ranucci A; Kim H; Mudra SE; Cashion AK; Townsley DM; Childs R; Paster BJ; Faller LL; Wallen GR
Ann Hematol; 2019 Jun; 98(6):1351-1365. PubMed ID: 30919073
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
Martynova A; Chiu V; Mert M; Hermel D; Weitz IC
Ann Hematol; 2021 Apr; 100(4):933-939. PubMed ID: 33420879
[TBL] [Abstract][Full Text] [Related]
17. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Treatment of Aplastic Anemia.
Peslak SA; Olson T; Babushok DV
Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
[TBL] [Abstract][Full Text] [Related]
19. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
Scheinberg P
Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
[TBL] [Abstract][Full Text] [Related]
20. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.
Yamazaki H; Ohta K; Iida H; Imada K; Obara N; Tokumine Y; Tomiyama Y; Usuki K; Imajo K; Miyamura K; Sasaki O; Fanghong Z; Hattori T; Tajima T; Matsuda A; Nakao S
Int J Hematol; 2019 Aug; 110(2):187-196. PubMed ID: 31183813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
